168 related articles for article (PubMed ID: 32314147)
1. Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
Wang L; Xiong C; Li M; Zeng X; Wang Q; Fang W; Zhao L
Ann Nucl Med; 2020 Jun; 34(6):407-414. PubMed ID: 32314147
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
[TBL] [Abstract][Full Text] [Related]
4. Platelet Distribution Width Level in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension and Its Diagnostic Value.
He Y; Yu Y; Hu S
Arch Rheumatol; 2020 Sep; 35(3):394-400. PubMed ID: 33458663
[TBL] [Abstract][Full Text] [Related]
5. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension.
Kazimierczyk R; Szumowski P; Nekolla SG; Blaszczak P; Malek LA; Milosz-Wieczorek B; Misko J; Jurgilewicz D; Hladunski M; Knapp M; Sobkowicz B; Mysliwiec J; Grzywna R; Musial WJ; Kaminski KA
Heart; 2021 Jan; 107(1):54-60. PubMed ID: 32522819
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study.
Wang L; Li W; Yang Y; Wu W; Cai Q; Ma X; Xiong C; He J; Fang W
Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1161-8. PubMed ID: 26588985
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
Nowak M; Carrasquillo JA; Yarboro CH; Bacharach SL; Whatley M; Valencia X; Takada K; Brust DG; Illei GG
Arthritis Rheum; 2004 Apr; 50(4):1233-8. PubMed ID: 15077306
[TBL] [Abstract][Full Text] [Related]
9. Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus.
Lee JH; Im Cho K
J Cardiol; 2014 Dec; 64(6):450-5. PubMed ID: 24755203
[TBL] [Abstract][Full Text] [Related]
10. (18)F-fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH.
Sumer C; Okumus G; Isik EG; Turkmen C; Bilge AK; Inanc M
Pulm Circ; 2024 Apr; 14(2):e12363. PubMed ID: 38618292
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Static and Dynamic
Braune A; Hofheinz F; Bluth T; Kiss T; Wittenstein J; Scharffenberg M; Kotzerke J; Gama de Abreu M
J Nucl Med; 2019 Nov; 60(11):1629-1634. PubMed ID: 31053684
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease.
Ohira H; deKemp R; Kadoya Y; Renaud J; Stewart DJ; Davies RA; Chandy G; Contreras-Dominguez V; Pugliese C; Dunne R; Beanlands R; Mielniczuk L
Ann Nucl Cardiol; 2022; 8(1):21-29. PubMed ID: 36540173
[No Abstract] [Full Text] [Related]
14. Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
Dai M; Zhang C; Li C; Wang Q; Gao C; Yue R; Yao M; Su Z; Zheng Z
Arthritis Res Ther; 2023 Aug; 25(1):155. PubMed ID: 37612772
[TBL] [Abstract][Full Text] [Related]
15. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M
Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Lun X; Yang J; Liu Y; Zhao F; Wei Z; Sun Y; Zhou X
Medicine (Baltimore); 2023 Dec; 102(51):e36654. PubMed ID: 38134088
[TBL] [Abstract][Full Text] [Related]
17. Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
Li J; Xiong J; Liu P; Peng Y; Cai S; Fang X; Yu S; Zhao J; Wu R
Adv Rheumatol; 2024 Feb; 64(1):15. PubMed ID: 38424650
[TBL] [Abstract][Full Text] [Related]
18. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
[TBL] [Abstract][Full Text] [Related]
20. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
